Global Life Science Analytics Market Size is Estimated to Reach USD 19,610.13 Million by 2031, Growing at a CAGR of 8.41%: Straits Research

The market is expanding as analytics solutions are increasingly used in pharmaceuticals and clinical trials. Pharmaceutical analytics solutions help companies speed up clinical trials by identifying and analyzing various data points, including participants’ demographic and historical information, data from remote patient monitoring, and information on previous clinical trial events. As a result, many pharmaceutical companies are increasingly implementing analytics solutions.

New York, United States, Jan. 31, 2024 (GLOBE NEWSWIRE) — Life sciences analytics refers to any analytical tool used in clinical research organizations, pharmaceutical and medical device companies, and various departments like research, supply chain, marketing, and pharmacovigilance. The key factors driving the life sciences analytics market are the need for better patient outcomes, the growing adoption of analytics solutions in pharmaceuticals and clinical trials, the pressure to reduce healthcare spending, and the appearance of advanced analytics techniques in life science companies.

Download Free Sample Report PDF @ https://straitsresearch.com/report/life-science-analytics-market/request-sample

Rising Use of Analytics Solutions in Pharmacies and Clinical Trials Drives the Global Market

According to Straits Research, The global life science analytics market size was valued at USD 9.481.05 million in 2022. It is expected to reach USD 19,610.13 million by 2031, growing at a CAGR of 8.41% during the forecast period (2023–2031). The market is growing as analytics tools are used more frequently in pharmaceuticals and clinical trials. By identifying and analyzing various data points, such as participant demographic and historical information, data from remote patient monitoring, and details on previous clinical trial events, pharmaceutical analytics solutions assist businesses in hastening clinical trials. As a result, numerous pharmaceutical firms are using analytics solutions more frequently. For instance, Amazon Web Services, Inc. (AWS), a division of Amazon.com, Inc., announced in December 2021 that it was working with Pfizer to create cutting-edge cloud-based solutions that could improve the procedure for developing, producing, and distributing new medications for use in clinical trials.

Development of Novel Analytics-Based Products and Solutions Creates Tremendous Opportunities

The global life science analytics market is anticipated to grow significantly over the coming years, increasing the market’s potential for growth. This can be attributed to the introduction of novel technologies, the demand for early diagnosis, and the growing emphasis on research and development, leading to the development of novel analytics-based products and solutions for the life sciences industry. For instance, in April 2021, Clarivate PLC reported that Cortellis Deals Intelligence, a premier source of information on life science deals, had improved. In order to speed up innovation, Clarivate PLC is a world leader in providing reliable information and insights. With the help of two new features, users can now confidently monitor the deal-making environment and quickly grasp the potential value of an asset. These features include predictive analytics and deal trend visualizations.

Regional Analysis

North America is the most significant contributor to the market and is expected to grow at a CAGR of 7.40% during the forecast period. The US life science analytics market is anticipated to grow significantly over the forecast period due to the introduction of new data and analytics solutions in the country and the strategic initiatives market players take. The country’s adoption of data and analytics solutions is anticipated to boost data management services, improve patient outcomes, and shorten the R&D cycle. For instance, in March 2022, Databricks unveiled the Databricks Lakehouse platform for healthcare and life science. A single platform supports data management, analytics, and cutting-edge AI use cases like disease prediction, medical image classification, and biomarker discovery. In addition, future adoption of data and analytical solutions is also anticipated to increase due to strategic actions taken by market participants, such as partnerships and the launch of awareness campaigns.

Europe is expected to grow at a CAGR of 7.88% during the forecast period. This market is expected to expand due to several factors, including increased product launches, expanding distribution agreements between crucial market participants, company service expansion, and increasing life science companies’ R&D expenditures. Growing distribution agreements between life science firms and suppliers of analytic solutions will likely lead to increased adoption of life science analytics solutions in Germany, which will support market expansion in this nation. For instance, in June 2021, JADBio and QIAGEN agreed to market and sell each other’s services as a part of the QIAGEN Digital Insights portfolio. This collaboration gave JADBio access to unmatched resources in the industry and a team of experts from around the world.

Key Highlights

  • Based on the product, the global life science analytics market is bifurcated into descriptive, predictive, and prescriptive analytics. The descriptive analytics segment is the highest contributor to the market and is expected to grow at a CAGR of 7.23% during the forecast period.
  • Based on the application, the global life science analytics market is bifurcated into research and development, supply chain analytics, and sales and marketing. The sales and marketing segment owns the highest market share and is expected to grow at a CAGR of 7.34% during the forecast period.
  • Based on the component, the global life science analytics market is bifurcated into software and service. The service segment is the highest contributor to the market and is expected to grow at a CAGR of 8.40% during the forecast period.
  • Based on the end-user, the global life science analytics market is bifurcated into clinical research institutions, pharmaceutical and biotechnology companies, and medical device companies. The pharmaceutical and biotechnology companies segment owns the highest market share and is expected to grow at a CAGR of 7.46% during the forecast period.
  • North America is the most significant contributor to the market and is expected to grow at a CAGR of 7.40% during the forecast period.

Competitive Players

The global life science analytics market’s major key players are Accenture, Cognizant, IBM Corporation, MaxisIT, Oracle Corporation, IQVIA, Sas Institute Inc., EXL Service (Scioinspire Corp.), Take Solutions Limited, Wipro Limited, Dynata, M3 (Eu) Ltd, Serma Group, and Apollo Intelligence.

Market News

  • In January 2023, Trinity Life Sciences, a global leader in life sciences solutions, and Havas Health & You (HHY&Y), the world’s largest global health and wellness network and part of Havas Group, a Vivendi (VIV) business, announced a strategic partnership that will allow both companies to offer cohesive end-to-end commercial solutions to the life sciences industry.

Global Life Science Analytics Market: Segmentation

By Product Type

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics

By Applications

  • Research and Development
  • Supply Chain Analytics
  • Sales and Marketing

By Component

  • Software
  • Service

By End User

  • Clinical Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies

By Regions

  • North America
  • Europe
  • Asia-Pacific
  • The Middle East and Africa
  • South America

Get Detailed Market Segmentation @ https://straitsresearch.com/report/life-science-analytics-market/segmentation

About Straits Research Pvt. Ltd.                     

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 480 7505 (the U.S.)
+91 8087085354 (APAC)
+44 208 068 9665 (the U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.